1-5 of 5
A. Michael Lincoff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT

Ildiko Lingvay, John Deanfield, Steven E. Kahn, Peter E. Weeke, Hermann Toplak, Benjamin M. Scirica, Lars Rydén, Naveen Rathor, Jorge Plutzky, Cristobal Morales, A. Michael Lincoff, Michael Lehrke, Ole Kleist Jeppesen, Grzegorz Gajos, Helen M. Colhoun, Bertrand Cariou, Donna Ryan, SELECT Trial Investigators
Journal: Diabetes Care
Diabetes Care 2024;47(8):1360–1369
https://doi.org/10.2337/dc24-0764
Published: 22 June 2024
View articletitled, Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT
Open the PDF for Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT in another window
Journal Articles

Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial

Steven E. Kahn, John E. Deanfield, Ole Kleist Jeppesen, Scott S. Emerson, Trine Welløv Boesgaard, Helen M. Colhoun, Robert F. Kushner, Ildiko Lingvay, Bartolome Burguera, Grzegorz Gajos, Deborah Bade Horn, Irene M. Hramiak, Ania M. Jastreboff, Alexander Kokkinos, Michael Maeng, Ana Laura S.A. Matos, Francisco J. Tinahones, A. Michael Lincoff, Donna H. Ryan, SELECT Trial Investigators
Journal: Diabetes Care
Diabetes Care 2024;47(8):1350–1359
https://doi.org/10.2337/dc24-0491
Published: 22 June 2024
View articletitled, Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial
Open the PDF for Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial in another window
Journal Articles

The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE

Nishant P. Shah, Qiuqing Wang, Katherine E. Wolski, Leslie Cho, Ellen McErlean, Giacomo Ruotolo, Govinda Weerakkody, Jeffrey S. Riesmeyer, Stephen J. Nicholls, A. Michael Lincoff, Steven E. Nissen, Venu Menon
Journal: Diabetes Care
Diabetes Care 2020;43(2):e22–e24
https://doi.org/10.2337/dc19-1117
Published: 05 December 2019
View articletitled, The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE
Open the PDF for The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE in another window
Journal Articles

Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial

Venu Menon, A. Michael Lincoff, Stephen J. Nicholls, Susan Jasper, Kathy Wolski, Darren K. McGuire, Cyrus R. Mehta, Julio Rosenstock, Claudia Lopez, John Marcinak, Charlie Cao, Steven E. Nissen
Journal: Diabetes Care
Diabetes Care 2018;41(12):2603–2609
https://doi.org/10.2337/dc18-0755
Published: 12 November 2018
View articletitled, Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial
Open the PDF for Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial in another window
Includes: Supplementary data
Journal Articles

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Ilse C. Schrieks, Anna Nozza, Barbara E. Stähli, John B. Buse, Robert R. Henry, Klas Malmberg, Bruce Neal, Stephen J. Nicholls, Lars Rydén, Linda Mellbin, Anders Svensson, Hans Wedel, Arlette Weichert, A. Michael Lincoff, Jean-Claude Tardif, Diederick E. Grobbee, Gregory G. Schwartz
Journal: Diabetes Care
Diabetes Care 2018;41(8):1792–1800
https://doi.org/10.2337/dc18-0158
Published: 14 June 2018
View articletitled, Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome
Open the PDF for Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome in another window
Includes: Supplementary data